Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by PoorOpinion on Apr 20, 2016 8:45am

More news out today

I found a link with a simple explanation of the pdufa date if people were wondering what it meant

https://www.eyeonfda.com/eye_on_fda/2010/07/what-is-pdufa.html
"What is a PDUFA date?  The new system established set time periods for the FDA to review a new application, usually set at a 10-month period.  If a drug, however, gets a priority review designation, then the review time will be set at 6 months.  (A priority review is given to drugs that offer a significant new breakthrough in treatment, or offer a treatment where none or few exist, and can be given for a drug which treats a serious condition as well as those that treat less serious conditions).  The timing for the clock to tick begins when the company submits the new drug application to the FDA.  The date is a target for FDA, but the agency can, and many times does, announce a decision prior to the PDUFA date.  "
Comment by 2quick154 on Apr 20, 2016 11:45am
Approval could come anytime now - my guess would be 1-2 months from now.
Comment by Floridas2000 on Apr 20, 2016 12:45pm
With such a low volume it feels like the stock is being surpressed.  Also, no-one cares about good news.  That tells me the market is being irrational about this stock.
Comment by kuatolives on Apr 20, 2016 10:32pm
I'm sure we'll see some kind of a pop once the drug is approved then followed by lots of selling into the strength as people get back to even or take some profits. And that's fine. The real growth in the sp will likely happen once we start getting a couple of quarters of Yosprala on the books and revenues start to substantially grow. We'll have one more quarter here with a high ...more  
Comment by kuatolives on Apr 21, 2016 4:20pm
Glad to see the concordia takeout rumours today. We need some excitement happening in this sector again. Get some money flowing.
Comment by Bigboyone on Apr 21, 2016 4:22pm
Kuto, I agree 100% there will selling into the strength...No doubt, but it will be many couponer's who have free shares.. Heres where I disagree .No one on the Tribute or Pozen end has a profit...(unless you bought years ago at 33c.. Our Value is 50c right now (.154 x $4.00) and Pozen turned to Aralez @ $6.50. The Exit doors will be wide open for sharholders who want an exit and they are gonna ...more  
Comment by kuatolives on Apr 21, 2016 4:30pm
Oh yeah I agree, I was referring to short term traders taking profits, not any kind of long term holders who have all been given the proverbial shaft. Hopefully yosprala will get approved sooner than later and they'll get to their 200M projections also sooner than later. It's all about the earnings now, and that's rightlyfully so. Adams keeps dropping how we're 'ogranically ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities